CMPS — COMPASS Pathways plc
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1816590 ·
Last close
$11.35
Market Cap
$1.53B
52W High
$15.40
52W Low
$8.76
ADV30
4,213,441
Next earnings
2026-08-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -40,427,000 | 91,202,000 | 531,739,000 | 466,010,000 | 205,052,000 |
| Dec 2025 | 0 | — | -58,864,000 | -93,878,000 | 210,349,000 | 149,608,000 | 263,197,000 |
| Sep 2025 | 0 | — | -36,612,000 | -137,717,000 | 255,607,000 | 185,937,000 | 218,016,000 |
| Jun 2025 | 0 | — | -38,646,000 | -38,403,000 | 293,536,000 | 221,881,000 | 130,981,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-159,519,000
Investing CF
$0
Financing CF
$362,807,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-3.15
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-731,392,000
Inventory
—
Receivables
$15,130,000
ST Investments
—
EBIT TTM
$-176,776,000
Pretax Income TTM
$-181,634,000
Interest Exp TTM
$4,858,000
Analysts
15
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -175,290,000 | -287,862,000 | 210,349,000 | 263,197,000 | — | -157,240,000 |
| Dec 2024 | 0 | -157,108,000 | -155,122,000 | 213,666,000 | 58,971,000 | — | -119,186,000 |
| Dec 2023 | 0 | -124,044,000 | -118,464,000 | 275,987,000 | 50,243,000 | — | -97,376,000 |
| Dec 2022 | 0 | -95,979,000 | -91,505,000 | 197,294,000 | 16,014,000 | — | -105,451,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
$1,977,000
NetIncome TTM
$-54,351,000
OpCashFlow TTM
$0
Assets (Latest)
$213,666,000
Forward EPS
$-1.34
Max Pain — expiry 2026-08-21
max pain strike: $11.00 · spot: $11.35 · call oi: 34,309 · put oi: 16,231
Expected Move to 2026-08-21:
±$2.20
(19.38%) —
implied range
$9.15 –
$13.55
· ATM straddle on $11.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TRAX | First Tracks Biotherapeutics, Inc. | $1.54B | $44.04 | — |
| INVA | Innoviva, Inc. | $1.55B | $20.97 | — |
| SEPN | Septerna, Inc. | $1.55B | $34.45 | — |
| XNCR | Xencor Inc | $1.50B | $20.21 | — |
| MLTX | MoonLake Immunotherapeutics | $1.57B | $18.44 | — |
News headlines (Yahoo Finance, 1h cache)
Compass Pathways to Announce Second Quarter and First Half 2026 Financial Results on August 5, 2026
2026-07-29 10:30 · Yahoo
Eli Lilly Is Acquiring AtaiBeckley for $2.8 Billion. Cathie Wood Thinks Another Psychedelic Drug Stock Is an Even Better Bet.
2026-07-29 09:20 · Yahoo
CMPS, MDGL, DFTX, GHRS, HELP Stocks In Spotlight Today – Why Wells Fargo Thinks Next Wave Of Depression Drugs Could Create New Winners
2026-07-27 14:38 · Yahoo
Psychedelic Therapy Meets M&A: Fireside Chat with Jupiter Neurosciences CEO Christer Rosén & President Alison Silva
2026-07-22 17:25 · Yahoo
Compass Pathways gains Jefferies support as COMP360 data distinguishes psychological support from psychotherapy
2026-07-17 16:50 · Yahoo
European Equities Traded in the US as American Depositary Receipts Decline Friday
2026-07-17 14:57 · Yahoo
COMPASS Pathways (CMPS) Is Down 8.6% After Phase 3 Durability Data For COMP360 In TRD
2026-07-17 07:12 · Yahoo
Stock Market Today, July 16: AtaiBeckley Surges on Eli Lilly Acquisition Worth Up To $3.8 Billion
2026-07-16 21:19 · Yahoo
European Equities Traded in the US as American Depositary Receipts Edge Lower Thursday
2026-07-16 15:16 · Yahoo
Why Psychedelic stocks are surging today
2026-07-16 11:44 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.